Concepedia

Author

Hitoshi Kusaba

Kyushu UniversityORCID

Also Known As

H Kusaba, H. Kusaba, HITOSHI KUSABA, Hitoshi Kusaba

170

Publications

2.4K

Citations

26

H-Index

73

Concepts

All Affiliations

Kyushu UniversityNational Hospital Organization Kyushu Cancer CenterHamanomachi HospitalNational Kyushu Medical CenterKyushu University Hospital
HK

About

Hitoshi Kusaba is an author at Kyushu University specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

28

956

2

Health Sciences

10

10

365

3

Natural Sciences

2

2

117

4

Engineering

1

1

21

5

Allergy

1

1

36

Hitoshi Kusaba

×

58

Publications

2.1K

Citations

26

H-Index

YearCitations

Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias

Morimasa Wada, Taishi Harada, Jun Nagayama,

Blood

1998

164

Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias

Morimasa Wada, Taishi Harada, Jun Nagayama,

Blood

1998

134

Effect of Promoter Methylation on the Regulation of <i>IFN-</i> γ Gene During In Vitro Differentiation of Human Peripheral Blood T Cells into a Th2 Population

Shingo Yano, Paritosh Ghosh, Hitoshi Kusaba,

The Journal of Immunology

2003

112

Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer

Michitaka Nakano, Yoshikane Kikushige, Kohta Miyawaki,

Oncogene

2018

111

RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells

Nobuhiro Tsuruta, Kenji Tsuchihashi, Hirofumi Ohmura,

Biochemical and Biophysical Research Communications

2020

101

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Hirofumi Ohmura, Fumiyasu Hanamura, Mamoru Ito,

British Journal of Cancer

2020

85

Phase I/<scp>II</scp> trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (<scp>JCOG</scp>0807)

Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa,

Cancer Science

2014

71

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer

Mamoru Ito, Hirofumi Ohmura, Fumiyasu Hanamura,

OncoImmunology

2020

70

Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells

Hitoshi Kusaba, Taishi Harada, Minoru Nomoto,

European Journal of Biochemistry

1999

66

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano,

Gastric Cancer

2017

56

Page 1